Industry News
Related Searches:
Filter by:
1456 - 1470 of 2391 results
February 27, 2009
Genzyme received approval from the European Commission for the production of Myozyme (alglucosidase alfa) at the 4000 liter bioreactor scale at its manufacturing facility in Geel, Belgium.
Read More »
February 26, 2009
Covance is expanding its biotechnology services facility in Harrogate, UK. The company also received a cGMP Manufacturing License from the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK.
Read More »
February 26, 2009
Akela Pharma's wholly owned subsidiary, PharmaForm, has signed a development agreement with an undisclosed global pharmaceutical company, to develop specialized oral dosage forms at its Austin, TX facility.
Read More »
February 25, 2009
Elan, as part of its restructuring efforts to manage costs and make additional investments in its pipeline, will suspend biologics manufacturing activities and cut approximately 230 positions, or 14% of the company’s workforce.
Read More »
February 25, 2009
Otsuka America Pharmaceutical, Inc. (OAPI) and Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) will restructure in an effort to grow the pharmaceutical business worldwide.
Read More »
February 23, 2009
Orexo AB will acquire PharmaKodex Ltd., a UK-based drug delivery company with several ready-to-partner preclinical and early clinical projects focused on improving oral, sublingual and transdermal medication.
Read More »
February 20, 2009
UCB plans to build a biologics pilot plant at its site Braine-l'Alleud in Belgium, as part of the company's efforts to focus on central nervous system (CNS) and immunology.
Read More »
February 20, 2009
Shire has signed a $70 million agreement with UCB to acquire the worldwide rights to Equasym IR and XL (methylphenidate hydrochloride), excluding the U.S., Canada and Barbados, for the treatment of ADHD.
Read More »
February 20, 2009
Therapure BioPharma, Inc. has been selected by LFB Biotechnologies, a subsidiary of LFB SA, for the development of a manufacturing method for a plasma therapeutic protein.
Read More »
February 19, 2009
A new study conducted by IBM and Silico Research showed that biopharmaceutical companies that do not partner or collaborate with other companies, risk delays in the production of new medicines, medical devices, diagnostics and support services.
Read More »
February 18, 2009
Almac Clinical Services opened an additional storage facility at its EU headquarters in Craigavon for cold-chain and controlled clinical supply storage.
Read More »
February 18, 2009
PharmaNet Development Group opened a new office in Sao Paulo, Brazil. The new office is part of the company's efforts to provide services in this region, which is considered to be a desired location for clinical research due to its qualified investigators
Read More »
February 13, 2009
WIL Research Laboratories has acquired Midwest BioResearch (MBR). The two companies will integrate their service offerings and share best practices and marketing.
Read More »
February 13, 2009
Portola Pharmaceuticals has entered into an exclusive worldwide license agreement with Novartis. Novartis will develop and commercialize Portola's intravenous (i.v.) and oral P2Y12 ADP receptor antagonist, elinogrel, currently in Phase II as a potential a
Read More »
February 12, 2009
Merck has entered into an agreement with Insmed, Inc. to purchase its portfolio of follow-on biologic therapeutic candidates and its commercial manufacturing facilities in Boulder, CO for $130 million in cash.
Read More »
1456 - 1470 of 2391 results
